ClinicalTrials.Veeva

Menu

Telemedicine Clinic for Prostate Cancer Patients

G

Grand River Hospital

Status

Unknown

Conditions

Cancer, Treatment-Related

Treatments

Other: Visits conducted via Telemedicine

Study type

Interventional

Funder types

Other

Identifiers

NCT03413865
OTN Study

Details and patient eligibility

About

This randomized, open label study will evaluate a nurse and pharmacist led clinic conducted remotely from Grand River Regional Cancer Centre at Grand River Hospital (GRRCC/GRH) using OTN teleconferencing as a platform for patients with prostate cancer receiving oral chemotherapy agents.

Enrollment

80 estimated patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Male over 18 years of age with prostate cancer receiving oral treatment with abiraterone or enzalutamide.
  2. Ability to provide consent to study.
  3. Willingness to complete study questionnaires and a semi-structured exit interview.
  4. Adequate command of the English language to complete study questionnaire and survey.
  5. Access to technology to allow a link to the virtual telemedicine clinic. (excluding control group)
  6. Willingness to participate in videoconference with pharmacist or nurse from their home environment. (excluding control group)

Exclusion criteria

  1. Patients receiving oral anti-cancer therapy other than abiraterone and enzalutamide.

  2. Patients lacking the technology at home to participate in the virtual telemedicine clinic. (excluding control group)

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

80 participants in 2 patient groups

OTN virtual clinic
Experimental group
Description:
Pharmacist and nurse led OTN based remote teleconference based clinic (OTN) The OTN clinic will be conducted by providing the patient with a link via email which will allow the patient to access OTN teleconferencing and meet virtually with a pharmacist and nurse during a previously scheduled appointment. Virtual clinic appointments will be 30 minutes long and will consist of a patient assessment and open ended questions about the patient health status using a modified version of the validated MOATT (MASCC Oral Agent Teaching Tool) created by the Multidisciplinary Association of Supportive Care in Cancer.
Treatment:
Other: Visits conducted via Telemedicine
In person Visits
No Intervention group
Description:
Patients are followed in person at the cancer clinic based on standard of care guidelines

Trial contacts and locations

1

Loading...

Central trial contact

Stacey Hubay, MD, FRCPC; Carla Girolametto, MA, MHSC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems